The GHIT Fund is an international organization that
supports product development, such as drugs and vaccines,
for malaria, tuberculosis and neglected tropical diseases (NTDs).
- We fight neglected diseases through partnerships
Diseases "neglected" by the world
-
-
Malaria
Deaths in 2021
619,000*
-
-
-
Tuberculosis
Deaths in 2021
1.6M*
-
-
-
NTDs
Cases in 2021
1.6B*
-
Despite the many people suffering from various infectious diseases, such as malaria,
tuberculosis, and neglected tropical diseases (NTDs), they have been
By comparison:
Deaths from lung
cancer in Japan
76,000*
In 2021
Why developing new drugs for
neglected diseases is so difficult
-
This makes it difficult for companies to participate in product development
-
Patients are caught in a vicious cycle
-
- Our vision is a world free of neglected infectious diseases that affect over a billion people. Our aim: achieving health equity.
-
- We leverage Japanese innovation and leadership to fight against neglected infectious diseases through investing in research and development and promoting global partnerships.
Our approach
- The GHIT Fund is an international non-profit organization that supports product development of drugs, vaccines, and diagnostics for malaria, tuberculosis, and NTDs that are difficult for companies to invest in alone. We fundraise through global public-private partnerships.
-
Fundraising
-
Invest in R&D
-
Support delivery to patients
GHIT by the numbers
-
- Total Investment
- Over USD300M**
-
- Total Invested Programs
- Over 120
-
- Total Product
Development Partners - Over 170
- Total Product
-
- Clinical Trials
- Over 10 projects
-
- Registration
- 1 projects
Goals to be achieved by 2027
Support from partners
- It’s virtually impossible for a single company to develop a product alone.
- The GHIT Fund is funded by the Government of Japan, United Nations Development Programme (UNDP), the pharmaceutical industry, the Bill & Melinda Gates Foundation, and Wellcome, as well as sponsors from a variety of private companies.
Tackling neglected infectious
diseases through global partnerships
- The GHIT Fund serves as a networking hub to accelerate product development by connecting Japanese and global institutions, including governments, private companies, foundations, NGO/NPOs, and UN agencies.
- Over60 Japanese
organizations - Over100 non-Japanese
organizations
Reference
- *World Health Organization Malaria Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/malaria
- *World Health Organization Tuberculosis Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/tuberculosis
- *World Health Organization NTDs. https://www.who.int/neglected_diseases/diseases/en/
- *National Cancer Center Hospital Statistics. https://ganjoho.jp/reg_stat/statistics/stat/summary.html#anchor3
- **GHIT invests using Japanese yen. US dollar amounts represent conversions from Japanese yen, solely for the reader’s convenience, at JPY 100 = USD 1.